• Genetic Testing
    In Making Genetics we offer a Genetic Testing service for those health professionals that want to give a personal service to each costumer. If you are a health professional Log In to get access to our services.
  • Research & Development
    Making Genetics is a young company devoted to the research & development of human genetic and epigenetic biomarkers.
  • Nutrigenomics
    Nutrigenomics is a branch of nutritional genomics and is defined as the study of the effects of foods and food constituents on gene expression.
  • Epigenetics
    In biology, epigenetics is the study of heritable changes in gene activity which are not caused by changes in the DNA sequence. The term also refers to functionally relevant changes along the genome that do not involve a change in the nucleotide sequence.
  • Bioinformatics
    Making Genetics manage the genomic-based projects, supporting the initial project design, determination of biomarkers, and offering statistical and biological interpretation of the results.
  • Pharmaco(epi)genetics
    Pharmacoepigenetics offers another level of explanation for interindividual variations in drug response that cannot be accounted for on the basis of genetic polymorphism. 


Making Genetics is a young company focused to the personalized medicine field. Our firm is led by a group of biologists with broad research experience in nutrigenomics, nutritional epidemiology and the study of genomics and epigenetics applied to cardiovascular and metabolic risk.

Beyond the genes, is currently emerging a branch of science called epigenetics. This term refers to the study of heritable changes in gene activity that are not caused by changes in the DNA sequence. The study of these epigenetic marks such as DNA methylation, may explain many health disorders that are caused by a negative interaction between genetic factors and environmental influences. The main objective of Making Genetics is to identify and develope new genetic and epigenetic combined panels for commercializing in clinic with diagnostic and prognostic purpose.

We currently have a R&D portfolio to improve with designed in-house genetic and epigenetic panels diagnostic/prognostic tests in different areas such as: autoimmune diseases, nutrigenetics in the elderly, stroke and metabolic syndrome.

As a contract research organization, we also offer to third parties the management of genomic-based research for biomarkers identification associated with the diagnosis and prognosis of several diseases and differential response to drugs. For this purpose, we offer a) the project design, b)the finding of new biomarkers through the use of -omics technologies, c) genomic interpretation of bioinformatic data, d) identification of biological mechanisms.

Submit to FacebookSubmit to Google PlusSubmit to TwitterSubmit to LinkedIn



ministerio de economía


COD 8 logo wis 130x50